港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

宝济药业-B

168.800

+2.3001.38%

成交量：80.48万

成交额：1.35亿

市值：550.26亿

市盈率：-139.85

高：168.800

开：166.500

低：164.600

收：166.500

52周最高：168.800

52周最低：56.000

股本：3.26亿

香港流通股本：1.54亿

量比：1.71

换手率：0.52%

股息：- -

股息率：- -

每股收益(LYR):-1.207

净资产收益率：--

总资产收益率：--

市净率：54.64

市盈率(LYR):-139.85

市销率: 1041.79

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

宝济药业－Ｂ(02659)出现大手买入5万股，成交价$167.0，涉资835万

阿斯达克财经

宝济药业-B(02659)获纳入恒生综合指数有望入选港股通开启价值重估

【IPO追踪】股价翻5倍，商业化刚起步：宝济药业的“甜蜜”能撑多久？

宝济药业-B02月12日主力净流入3547.9万元散户资金抛售

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02659"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02659","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","market":"HK","secType":"STK","nameCN":"宝济药业-B","latestPrice":168.8,"timestamp":1771214884596,"preClose":166.5,"halted":0,"volume":804800,"delay":0,"changeRate":0.013813813813813882,"floatShares":154000000,"shares":325981465,"eps":-1.207,"marketStatus":"农历年初三休市","change":2.3,"latestTime":"02-16 12:08:04","open":166.5,"high":168.8,"low":164.6,"amount":134773330,"amplitude":0.025225,"askPrice":168.8,"askSize":120800,"bidPrice":168.7,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.279,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771551000000},"marketStatusCode":7,"adr":0,"listingDate":1765296000000,"exchange":"SEHK","adjPreClose":166.5,"openAndCloseTimeList":[[1771205400000,1771214400000]],"volumeRatio":1.707830695276511,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","floatShares":154000000,"roa":"--","roe":"--","lyrEps":-1.207,"volumeRatio":1.707830695276511,"shares":325981465,"dividePrice":0,"high":168.8,"amplitude":0.025225,"preClose":166.5,"low":164.6,"week52Low":56,"pbRate":"54.64","psRate":"1041.79","week52High":168.8,"institutionHeld":0,"latestPrice":168.8,"committee":-0.998346,"eps":-1.207,"divideRate":0,"volume":804800,"delay":0,"ttmEps":-1.279,"open":166.5,"prevYearClose":77.55,"prevWeekClose":166.5,"prevMonthClose":104,"prevQuarterClose":77.55,"fiveDayClose":129.6,"twentyDayClose":104.5,"sixtyDayClose":26.38},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02659\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02659\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02659\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1769184000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02659\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02659","date":"2026-02-16","current":-131.978108,"percent":0,"low":-127.906317,"twenty":-79.096377,"median":-69.575275,"eighty":-56.073573,"high":-20.527356,"avg":-70.946383,"sd":20.401888,"marketCap":55025671292},"quantilePoints":[{"date":"2025-12-12","current":-53.146224,"twenty":-53.348389,"median":-51.086695,"eighty":-37.627242,"marketCap":22280833132},{"date":"2025-12-19","current":-56.628418,"twenty":-56.115318,"median":-53.146224,"eighty":-50.330094,"marketCap":23796646945},{"date":"2025-12-24","current":-60.667186,"twenty":-57.368285,"median":-54.841733,"eighty":-51.357726,"marketCap":25573245929},{"date":"2026-01-02","current":-53.689307,"twenty":-58.867149,"median":-56.13619,"eighty":-51.993778,"marketCap":22720908110},{"date":"2026-01-09","current":-60.663453,"twenty":-59.744205,"median":-56.240552,"eighty":-53.146224,"marketCap":25736236661},{"date":"2026-01-16","current":-77.814349,"twenty":-61.547088,"median":-57.565784,"eighty":-53.651638,"marketCap":33119716844},{"date":"2026-01-23","current":-76.125836,"twenty":-72.759479,"median":-58.867149,"eighty":-53.689307,"marketCap":32369959474},{"date":"2026-01-30","current":-79.366151,"twenty":-76.125836,"median":-60.665319,"eighty":-55.0155,"marketCap":33902072360},{"date":"2026-02-06","current":-84.493791,"twenty":-76.125836,"median":-61.547088,"eighty":-55.626475,"marketCap":36183942615},{"date":"2026-02-13","current":-126.016863,"twenty":-78.017279,"median":-67.830536,"eighty":-56.031828,"marketCap":54275913922},{"date":"2026-02-16","current":-127.906317,"twenty":-79.096377,"median":-69.575275,"eighty":-56.073573,"marketCap":55025671292}],"updateTime":1771460987743},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02659\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611170832","title":"宝济药业－Ｂ(02659)出现大手买入5万股，成交价$167.0，涉资835万","url":"https://stock-news.laohu8.com/highlight/detail?id=2611170832","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611170832?lang=zh_cn&edition=fundamental","pubTime":"2026-02-16 10:39","pubTimestamp":1771209540,"startTime":"0","endTime":"0","summary":"[大手成交]宝济药业－Ｂ(02659)在上午10:39出现大手买入，成交量为5万，成交价为港币$167.0，涉资835万。至目前为止，股价升0.12%，今日最高价为$167.0，而最低价为$164.6，总成交量为22.39万股，总成交金额港币$3.737千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2602162965/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2602162965/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02659"],"gpt_icon":0},{"id":"2611658168","title":"宝济药业-B(02659)获纳入恒生综合指数 有望入选港股通开启价值重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2611658168","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611658168?lang=zh_cn&edition=fundamental","pubTime":"2026-02-13 22:05","pubTimestamp":1770991530,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2月13日，恒生指数公司宣布截至2025年12月31日之恒生指数系列季度检讨结果，其中宝济药业-B获纳入恒生综合指数。此次变动将于2026年3月6日(星期五)收市后实施并于2026年3月9日(星期一)起生效，届时沪深交易所会相应调整港股通可投资标的范围。据LiveReport大数据预测，宝济药业有望借此机会纳入港股通，迎来发展新契机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405477.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1161","VT","HSCI","02659","VXUS","BK4585"],"gpt_icon":0},{"id":"2611385192","title":"【IPO追踪】股价翻5倍，商业化刚起步：宝济药业的“甜蜜”能撑多久？","url":"https://stock-news.laohu8.com/highlight/detail?id=2611385192","media":"港股解码","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611385192?lang=zh_cn&edition=fundamental","pubTime":"2026-02-13 19:16","pubTimestamp":1770981405,"startTime":"0","endTime":"0","summary":"在2025年上半年4.20亿元的收入中，绝大部分来自一次性许可协议首付款，核心产品SJ02的商业化收入尚未形成规模，KJ017、KJ103仍处于审批或临床阶段，缺乏可持续的收入支撑。对于普通投资者而言，不应盲目追逐短期股价涨幅，而应重点关注公司三大核心指标：SJ02的商业化销售数据、KJ017的NDA审批进度、KJ103的III期临床结果。资本市场的狂欢终会回归理性，宝济药业的甜蜜能否延续，最终取决于其从“管线潜力”到“业绩兑现”的转化能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213193427a4a0a581&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213193427a4a0a581&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02659","BK1161"],"gpt_icon":0},{"id":"2611864681","title":"宝济药业-B02月12日主力净流入3547.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2611864681","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611864681?lang=zh_cn&edition=fundamental","pubTime":"2026-02-12 16:15","pubTimestamp":1770884148,"startTime":"0","endTime":"0","summary":"02月12日, 宝济药业-B股价涨2.62%，报收148.80元，成交金额1.2亿元，换手率0.52%，振幅14.14%，量比0.82。宝济药业-B今日主力资金净流入3547.9万元，上一交易日主力净流出213.7万元。该股近5个交易日上涨51.68%，主力资金累计净流入3335.9万元；近20日主力资金累计净流入3543.8万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212162022a49b8f88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212162022a49b8f88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02659"],"gpt_icon":0}],"pageSize":4,"totalPage":18,"pageCount":1,"totalSize":70,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02659\",params:#limit:6,delay:false,,,undefined,":[]}}